Tuning P450 Enzymes as Oxidation Catalysts
暂无分享,去创建一个
[1] L. Wong,et al. The catalytic activity of cytochrome P450cam towards styrene oxidation is increased by site‐specific mutagenesis , 1997, FEBS letters.
[2] Frances H Arnold,et al. Directed enzyme evolution: climbing fitness peaks one amino acid at a time. , 2009, Current opinion in chemical biology.
[3] P. Grootenhuis,et al. Efficient Screening of Cytochrome P450 BM3 Mutants for Their Metabolic Activity and Diversity toward a Wide Set of Drug-Like Molecules in Chemical Space , 2011, Drug Metabolism and Disposition.
[4] O. Shoji,et al. Aromatic C–H bond hydroxylation by P450 peroxygenases: a facile colorimetric assay for monooxygenation activities of enzymes based on Russig’s blue formation , 2010, JBIC Journal of Biological Inorganic Chemistry.
[5] J. Falck,et al. An Active Site Substitution, F87V, Converts Cytochrome P450 BM-3 into a Regio- and Stereoselective (14S,15R)-Arachidonic Acid Epoxygenase* , 1997, The Journal of Biological Chemistry.
[6] V. Urlacher,et al. Altering the Regioselectivity of Cytochrome P450 CYP102A3 of Bacillus subtilis by Using a New Versatile Assay System , 2006, Chembiochem : a European journal of chemical biology.
[7] K. Auclair,et al. Predictable stereoselective and chemoselective hydroxylations and epoxidations with P450 3A4. , 2011, Journal of the American Chemical Society.
[8] C. W. Fisher,et al. Human cytochrome P450 3A4: enzymatic properties of a purified recombinant fusion protein containing NADPH-P450 reductase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[9] Chiung-Kuang J. Chen,et al. Scanning chimeragenesis: the approach used to change the substrate selectivity of fatty acid monooxygenase CYP102A1 to that of terpene ω-hydroxylase CYP4C7 , 2010, JBIC Journal of Biological Inorganic Chemistry.
[10] T. Shimada,et al. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification. , 1996, Archives of biochemistry and biophysics.
[11] O. Shoji,et al. Understanding substrate misrecognition of hydrogen peroxide dependent cytochrome P450 from Bacillus subtilis , 2010, JBIC Journal of Biological Inorganic Chemistry.
[12] Tristan R. Brown,et al. Engineered Bacterial Mimics of Human Drug Metabolizing Enzyme CYP2C9 , 2011 .
[13] H. Murakami,et al. Expression of bovine cytochrome P450c21 and its fused enzymes with yeast NADPH-cytochrome P450 reductase in Saccharomyces cerevisiae. , 1990, DNA and cell biology.
[14] B. Gabriele,et al. Catalytic oxidations of steroid substrates by artificial cytochrome p-450 enzymes. , 2002, The Journal of organic chemistry.
[15] Frances H Arnold,et al. Evolutionary history of a specialized p450 propane monooxygenase. , 2008, Journal of molecular biology.
[16] Heung-Chae Jung,et al. ENGINEERING BACTERIAL CYTOCHROME P450 BM3 INTO A PROTOTYPE WITH HUMAN P450 ENZYME ACTIVITY USING INDIGO FORMATION , 2010 .
[17] Nicholas J Turner,et al. Engineering and improvement of the efficiency of a chimeric [P450cam-RhFRed reductase domain] enzyme. , 2009, Chemical communications.
[18] C. Wolf,et al. Merits and limitations of recombinant models for the study of human P450-mediated drug metabolism and toxicity: an intralaboratory comparison. , 1999, Drug metabolism reviews.
[19] G. Brudvig,et al. High turnover remote catalytic oxygenation of alkyl groups: how steric exclusion of unbound substrate contributes to high molecular recognition selectivity. , 2008, Journal of the American Chemical Society.
[20] W U Primrose,et al. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation. , 1997, Biochemistry.
[21] Martin Stahl,et al. Fluorine in Medicinal Chemistry , 2004, Chembiochem : a European journal of chemical biology.
[22] Rudi Fasan,et al. P450 fingerprinting method for rapid discovery of terpene hydroxylating P450 catalysts with diversified regioselectivity. , 2011, Journal of the American Chemical Society.
[23] Timothy S. Ham,et al. Production of the antimalarial drug precursor artemisinic acid in engineered yeast , 2006, Nature.
[24] M. Budde,et al. Selective Hydroxylation of Highly Branched Fatty Acids and their Derivatives by CYP102A1 from Bacillus megaterium , 2006, Chembiochem : a European journal of chemical biology.
[25] H. Griengl,et al. The use of substrate engineering in biohydroxylation. , 2002, Current opinion in biotechnology.
[26] Jullien Drone,et al. A regioselective biocatalyst for alkane activation under mild conditions. , 2011, Angewandte Chemie.
[27] D. Sherman,et al. Engineering and analysis of a self-sufficient biosynthetic cytochrome P450 PikC fused to the RhFRED reductase domain. , 2007, Journal of the American Chemical Society.
[28] I. Schlichting,et al. Structural aspects of ligand binding to and electron transfer in bacterial and fungal P450s. , 2004, Annual review of biochemistry.
[29] O. Gotoh,et al. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. , 1992, The Journal of biological chemistry.
[30] Vlada B Urlacher,et al. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes. , 2011, Chemical communications.
[31] C. W. Fisher,et al. The omega-hydroxlyation of lauric acid: oxidation of 12-hydroxlauric acid to dodecanedioic acid by a purified recombinant fusion protein containing P450 4A1 and NADPH-P450 reductase. , 1996, Archives of biochemistry and biophysics.
[32] M. Koffas,et al. Engineering Central Metabolic Pathways for High-Level Flavonoid Production in Escherichia coli , 2007, Applied and Environmental Microbiology.
[33] T. Poulos,et al. High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.
[34] J. Capdevila,et al. Biochemical characterization of rat P450 2C11 fused to rat or bacterial NADPH-P450 reductase domains. , 2000, Biochemistry.
[35] H. Sugimoto,et al. Crystal structure of H2O2-dependent cytochrome P450SPalpha with its bound fatty acid substrate: insight into the regioselective hydroxylation of fatty acids at the alpha position. , 2011, The Journal of biological chemistry.
[36] L. Sayavedra-Soto,et al. Molecular analysis of the soluble butane monooxygenase from 'Pseudomonas butanovora'. , 2002, Microbiology.
[37] Frances H. Arnold,et al. Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase , 2002, Nature Biotechnology.
[38] M. Sanford,et al. Palladium-catalyzed oxygenation of unactivated sp3 C-H bonds. , 2004, Journal of the American Chemical Society.
[39] Denis Pompon,et al. Self-sufficient biosynthesis of pregnenolone and progesterone in engineered yeast , 1998, Nature Biotechnology.
[40] F. Diederich,et al. Fluorine in Pharmaceuticals: Looking Beyond Intuition , 2007, Science.
[41] Kersten S. Rabe,et al. Engineering and assaying of cytochrome P450 biocatalysts , 2008, Analytical and bioanalytical chemistry.
[42] E. Gillam,et al. A shuffled CYP2C library with a high degree of structural integrity and functional versatility. , 2007, Archives of biochemistry and biophysics.
[43] Michael T. Green,et al. Cytochrome P450 Compound I: Capture, Characterization, and C-H Bond Activation Kinetics , 2010, Science.
[44] A. Burlingame,et al. Cytochrome P450cin (CYP176A), Isolation, Expression, and Characterization* , 2002, The Journal of Biological Chemistry.
[45] J. Groves. The bioinorganic chemistry of iron in oxygenases and supramolecular assemblies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[46] K. Godula,et al. C-H Bond Functionalization in Complex Organic Synthesis , 2006, Science.
[47] J Deisenhofer,et al. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. , 1993, Science.
[48] U. Mueller,et al. Structural fine-tuning of a multifunctional cytochrome P450 monooxygenase. , 2011, Journal of the American Chemical Society.
[49] Huimin Zhao,et al. Combinatorial Design of a Highly Efficient Xylose-Utilizing Pathway in Saccharomyces cerevisiae for the Production of Cellulosic Biofuels , 2012, Applied and Environmental Microbiology.
[50] O. Sibbesen,et al. Putidaredoxin Reductase-Putidaredoxin-Cytochrome P450cam Triple Fusion Protein , 1996, The Journal of Biological Chemistry.
[51] F. Arnold,et al. Catalysts on Demand: Selective Oxidations by Laboratory-Evolved Cytochrome P450 BM3 , 2009 .
[52] E. G. Funhoff,et al. CYP153A6, a Soluble P450 Oxygenase Catalyzing Terminal-Alkane Hydroxylation , 2006, Journal of bacteriology.
[53] F. Arnold,et al. Enzymatic functionalization of carbon-hydrogen bonds. , 2011, Chemical Society reviews.
[54] F. Arnold,et al. Engineering Cytochrome P450 BM3 for Terminal Alkane Hydroxylation , 2006 .
[55] T. Sakaki,et al. Molecular Engineering Study on Electron Transfer from NADPH-P450 Reductase to Rat Mitochondrial P450c27 in Yeast Microsomes* , 1996, The Journal of Biological Chemistry.
[56] Stephen G. Sligar,et al. Kinetic Characterization of Compound I Formation in the Thermostable Cytochrome P450 CYP119* , 2002, The Journal of Biological Chemistry.
[57] F. Arnold,et al. Diversification of catalytic function in a synthetic family of chimeric cytochrome p450s. , 2007, Chemistry & biology.
[58] N. Vermeulen,et al. Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis. , 2007, Journal of medicinal chemistry.
[59] Matthias Dietrich,et al. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions. , 2009, Journal of biotechnology.
[60] Paul N. Devine,et al. Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture , 2010, Science.
[61] T. Maier,et al. Molecular characterization of the 56-kDa CYP153 from Acinetobacter sp. EB104. , 2001, Biochemical and biophysical research communications.
[62] Chiung-Kuang J. Chen,et al. The effect of mutation of F87 on the properties of CYP102A1-CYP4C7 chimeras: altered regiospecificity and substrate selectivity , 2008, JBIC Journal of Biological Inorganic Chemistry.
[63] F. Arnold,et al. Protein stability promotes evolvability. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[64] W. Atkins,et al. Interactions of cytochrome P450s with their ligands. , 2011, Archives of biochemistry and biophysics.
[65] Qing-Shan Li,et al. Hydroxylation activity of P450 BM-3 mutant F87V towards aromatic compounds and its application to the synthesis of hydroquinone derivatives from phenolic compounds , 2005, Applied Microbiology and Biotechnology.
[66] Manfred T Reetz,et al. Tuning a p450 enzyme for methane oxidation. , 2011, Angewandte Chemie.
[67] F. Guengerich,et al. A tricistronic human adrenodoxin reductase-adrenodoxin-cytochrome P450 27A1 vector system for substrate hydroxylation in Escherichia coli. , 2011, Protein expression and purification.
[68] Micheal C. Wilson,et al. Shared biosynthesis of the saliniketals and rifamycins in Salinispora arenicola is controlled by the sare1259-encoded cytochrome P450. , 2010, Journal of the American Chemical Society.
[69] K. Inouye,et al. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast. , 2000, Archives of biochemistry and biophysics.
[70] D. Sherman,et al. Selective oxidation of carbolide C–H bonds by an engineered macrolide P450 mono-oxygenase , 2009, Proceedings of the National Academy of Sciences.
[71] Sabine Laschat,et al. Rational Design of a Minimal and Highly Enriched CYP102A1 Mutant Library with Improved Regio‐, Stereo‐ and Chemoselectivity , 2009, Chembiochem : a European journal of chemical biology.
[72] G. Brudvig,et al. Molecular Recognition in the Selective Oxygenation of Saturated C-H Bonds by a Dimanganese Catalyst , 2006, Science.
[73] R. Bernhardt,et al. Cytochrome P450 systems--biological variations of electron transport chains. , 2007, Biochimica et biophysica acta.
[74] U. Schwaneberg,et al. A P450 BM-3 mutant hydroxylates alkanes, cycloalkanes, arenes and heteroarenes. , 2001, Journal of biotechnology.
[75] H. Inui,et al. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5. , 2007, Biochemistry.
[76] P. Fuchs,et al. Chemospecific chromium[VI] catalyzed oxidation of C-H bonds at -40 °C , 2002 .
[77] G. Gaskell. Science policy and society: the British debate over GM agriculture. , 2004, Current opinion in biotechnology.
[78] R. Schmid,et al. Engineering Cytochrome P450 BM-3 for Oxidation of Polycyclic Aromatic Hydrocarbons , 2001, Applied and Environmental Microbiology.
[79] F. Guengerich,et al. Drug metabolism by Escherichia coli expressing human cytochromes P450 , 1997, Nature Biotechnology.
[80] T. Poulos,et al. The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid , 1997, Nature Structural Biology.
[81] M. Honing,et al. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11 , 2011, JBIC Journal of Biological Inorganic Chemistry.
[82] G. Gilardi,et al. Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego , 2005, JBIC Journal of Biological Inorganic Chemistry.
[83] O. Shoji,et al. Hydrogen peroxide dependent monooxygenations by tricking the substrate recognition of cytochrome P450BSbeta. , 2007, Angewandte Chemie.
[84] Rapid identification of cytochrome P450cam variants by in vivo screening of active site libraries , 2004 .
[85] L. Narhi,et al. Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium. , 1987, The Journal of biological chemistry.
[86] P. Hedden,et al. The P450–1 gene of Gibberella fujikuroi encodes a multifunctional enzyme in gibberellin biosynthesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[87] D. Sames,et al. Selective functionalization of amino acids in water: a synthetic method via catalytic C-H bond activation. , 2001, Journal of the American Chemical Society.
[88] S. Sligar,et al. Nucleotide sequence of the Pseudomonas putida cytochrome P-450cam gene and its expression in Escherichia coli. , 1986, The Journal of biological chemistry.
[89] P. Baran,et al. If C-H bonds could talk: selective C-H bond oxidation. , 2011, Angewandte Chemie.
[90] B. Witholt,et al. Preparation of (R)- and (S)-N-protected 3-hydroxypyrrolidines by hydroxylation with Sphingomonas sp. HXN-200, a highly active, regio- and stereoselective, and easy to handle biocatalyst. , 2001, The Journal of organic chemistry.
[91] S. Bell,et al. Biotransformation of the sesquiterpene (+)-valencene by cytochrome P450cam and P450BM-3. , 2005, Organic & biomolecular chemistry.
[92] Surendra S. Negi,et al. Conformational Flexibility of Mammalian Cytochrome P450 2B4 in Binding Imidazole Inhibitors with Different Ring Chemistry and Side Chains , 2006, Journal of Biological Chemistry.
[93] M. White,et al. Combined Effects on Selectivity in Fe-Catalyzed Methylene Oxidation , 2010, Science.
[94] H. Shoun,et al. Cytochrome P450foxy, a catalytically self-sufficient fatty acid hydroxylase of the fungus Fusarium oxysporum. , 1996, Journal of biochemistry.
[95] J. Dawson,et al. Reaction of Ferric Cytochrome P450cam with Peracids , 2005, Journal of Biological Chemistry.
[96] F Peter Guengerich,et al. Complex reactions catalyzed by cytochrome P450 enzymes. , 2007, Biochimica et biophysica acta.
[97] Ramesh N. Patel. Biocatalysis: Synthesis of Key Intermediates for Development of Pharmaceuticals , 2011 .
[98] Elizabeth M J Gillam,et al. Extending the diversity of cytochrome P450 enzymes by DNA family shuffling. , 2007, Gene.
[99] F. Arnold,et al. Improved product‐per‐glucose yields in P450‐dependent propane biotransformations using engineered Escherichia coli , 2011, Biotechnology and bioengineering.
[100] Frances H Arnold,et al. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3. , 2003, Journal of the American Chemical Society.
[101] C. Chiang,et al. Structures of Prostacyclin Synthase and Its Complexes with Substrate Analog and Inhibitor Reveal a Ligand-specific Heme Conformation Change* , 2008, Journal of Biological Chemistry.
[102] C. W. Fisher,et al. Comparison of the 17α-Hydroxylase/C17,20-Lyase Activities of Porcine, Guinea Pig and Bovine P450c17 Using Purified Recombinant Fusion Proteins Containing P450c17 Linked to NADPH-P450 Reductase , 2007, Drug metabolism reviews.
[103] G. Brudvig,et al. Molecular recognition in homogeneous transition metal catalysis: a biomimetic strategy for high selectivity. , 2008, Chemical communications.
[104] N. Kitteringham,et al. Metabolism of fluorine-containing drugs. , 2001, Annual review of pharmacology and toxicology.
[105] D. Sherman,et al. Hydroxylation of macrolactones YC-17 and narbomycin is mediated by the pikC-encoded cytochrome P450 in Streptomyces venezuelae. , 1998, Chemistry & biology.
[106] Imad Hanna,et al. Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli , 2005, Journal of Industrial Microbiology and Biotechnology.
[107] M. Waterman,et al. Studies of distant members of the P450 superfamily (P450scc and P450c27) by random chimeragenesis. , 1996, Archives of biochemistry and biophysics.
[108] J. Dawson,et al. Heme-Containing Oxygenases. , 1996, Chemical reviews.
[109] A. Alian,et al. Cytochrome P450 active site plasticity: attenuation of imidazole binding in cytochrome P450(cam) by an L244A mutation. , 2006, Protein engineering, design & selection : PEDS.
[110] A. Munro,et al. Roles of key active-site residues in flavocytochrome P450 BM3. , 1999, The Biochemical journal.
[111] P. Covello,et al. Artemisia annua L. (Asteraceae) trichome‐specific cDNAs reveal CYP71AV1, a cytochrome P450 with a key role in the biosynthesis of the antimalarial sesquiterpene lactone artemisinin , 2006, FEBS letters.
[112] F. Arnold,et al. Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. , 2006, Journal of the American Chemical Society.
[113] S. Bell,et al. Butane and propane oxidation by engineered cytochrome P450cam. , 2002, Chemical communications.
[114] N. Vermeulen,et al. Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450 BM3. , 2006, Biochemical and biophysical research communications.
[115] F. Guengerich. Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.
[116] C. Wolf,et al. Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein. , 2001, Archives of biochemistry and biophysics.
[117] F. Arnold,et al. Combinatorial Alanine Substitution Enables Rapid Optimization of Cytochrome P450BM3 for Selective Hydroxylation of Large Substrates , 2010, Chembiochem : a European journal of chemical biology.
[118] M. Schittmayer,et al. A Diversified Library of Bacterial and Fungal Bifunctional Cytochrome P450 Enzymes for Drug Metabolite Synthesis , 2009 .
[119] Keith E. J. Tyo,et al. Isoprenoid Pathway Optimization for Taxol Precursor Overproduction in Escherichia coli , 2010, Science.
[120] D. Haines,et al. Cloning, expression and characterization of a fast self-sufficient P450: CYP102A5 from Bacillus cereus. , 2007, Archives of biochemistry and biophysics.
[121] R. Bernhardt,et al. Cytochromes P450 as versatile biocatalysts. , 2006, Journal of biotechnology.
[122] D. Ro,et al. Loblolly pine abietadienol/abietadienal oxidase PtAO (CYP720B1) is a multifunctional, multisubstrate cytochrome P450 monooxygenase , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[123] J. Slattery,et al. CYP3A4-mediated oxidation of lisofylline to lisofylline 4,5-diol in human liver microsomes. , 1998, Journal of pharmaceutical sciences.
[124] M. Cryle,et al. Carbon-carbon bond cleavage by cytochrome p450(BioI)(CYP107H1). , 2004, Chemical communications.
[125] E. G. Funhoff,et al. Hydroxylation and epoxidation reactions catalyzed by CYP153 enzymes , 2007 .
[126] J. Falck,et al. The Highly Stereoselective Oxidation of Polyunsaturated Fatty Acids by Cytochrome P450BM-3* , 1996, The Journal of Biological Chemistry.
[127] U. Schwaneberg,et al. Directed evolution of oxygenases: screening systems, success stories and challenges. , 2007, Combinatorial chemistry & high throughput screening.
[128] Milton R. Smith,et al. C-H activation/borylation/oxidation: a one-pot unified route to meta-substituted phenols bearing ortho-/para-directing groups. , 2003, Journal of the American Chemical Society.
[129] R. Schmid,et al. Residue size at position 87 of cytochrome P450 BM‐3 determines its stereoselectivity in propylbenzene and 3‐chlorostyrene oxidation , 2001, FEBS letters.
[130] M. Sanford,et al. A highly selective catalytic method for the oxidative functionalization of C-H bonds. , 2004, Journal of the American Chemical Society.
[131] Andreas Schmid,et al. Practical issues in the application of oxygenases. , 2003, Trends in biotechnology.
[132] S. Takatsuto,et al. Arabidopsis CYP85A2, a Cytochrome P450, Mediates the Baeyer-Villiger Oxidation of Castasterone to Brassinolide in Brassinosteroid Biosynthesis , 2005, The Plant Cell Online.
[133] R D Schmid,et al. Directed evolution of the fatty-acid hydroxylase P450 BM-3 into an indole-hydroxylating catalyst. , 2000, Chemistry.
[134] Bernhard Hauer,et al. An Efficient Route to Selective Bio‐oxidation Catalysts: an Iterative Approach Comprising Modeling, Diversification, and Screening, Based on CYP102A1 , 2011, Chembiochem : a European journal of chemical biology.
[135] Youngchang Kim,et al. The Structural Basis for Substrate Anchoring, Active Site Selectivity, and Product Formation by P450 PikC from Streptomyces venezuelae* , 2006, Journal of Biological Chemistry.
[136] J. Halpert,et al. A Rational Approach to Re-engineer Cytochrome P450 2B1 Regioselectivity Based on the Crystal Structure of Cytochrome P450 2C5* , 2003, The Journal of Biological Chemistry.
[137] L. Wong,et al. Protein engineering of Bacillus megaterium CYP102. The oxidation of polycyclic aromatic hydrocarbons. , 2001, European journal of biochemistry.
[138] F. Arnold,et al. Thermostabilization of a Cytochrome P450 Peroxygenase , 2003, Chembiochem : a European journal of chemical biology.
[139] O. Shoji,et al. Use of perfluorocarboxylic acids to trick cytochrome P450BM3 into initiating the hydroxylation of gaseous alkanes. , 2011, Angewandte Chemie.
[140] Paul A Wender,et al. Late-stage intermolecular CH activation for lead diversification: a highly chemoselective oxyfunctionalization of the C-9 position of potent bryostatin analogues. , 2005, Organic letters.
[141] Frances H Arnold,et al. Enantioselective epoxidation of terminal alkenes to (R)- and (S)-epoxides by engineered cytochromes P450 BM-3. , 2006, Chemistry.
[142] Frances H Arnold,et al. Chemoenzymatic elaboration of monosaccharides using engineered cytochrome P450BM3 demethylases , 2009, Proceedings of the National Academy of Sciences.
[143] Raquel L Lieberman,et al. Biological Methane Oxidation: Regulation, Biochemistry, and Active Site Structure of Particulate Methane Monooxygenase , 2004, Critical reviews in biochemistry and molecular biology.
[144] F. Arnold,et al. Direct Conversion of Ethane to Ethanol by Engineered Cytochrome P450 BM3 , 2005, Chembiochem : a European journal of chemical biology.
[145] Jeffrey B. Endelman,et al. Structure-Guided Recombination Creates an Artificial Family of Cytochromes P450 , 2006, PLoS biology.
[146] I. Pikuleva. CHOLESTEROL-METABOLIZING CYTOCHROMES P450 , 2006, Drug Metabolism and Disposition.
[147] John H. White,et al. Probing the substrate specificity of the catalytically self-sufficient cytochrome P450 RhF from a Rhodococcus sp. , 2006, Chemical communications.
[148] M. White,et al. A Predictably Selective Aliphatic C–H Oxidation Reaction for Complex Molecule Synthesis , 2007, Science.
[149] V. Urlacher,et al. Biotransformation of β-ionone by engineered cytochrome P450 BM-3 , 2006, Applied Microbiology and Biotechnology.
[150] Jay D Keasling,et al. Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. , 2007, Nature chemical biology.
[151] G. Gilardi,et al. Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes , 2007, JBIC Journal of Biological Inorganic Chemistry.
[152] F. Arnold,et al. Stereoselective hydroxylation of an achiral cyclopentanecarboxylic acid derivative using engineered P450s BM-3. , 2005, Chemical communications.
[153] L. Wong,et al. Protein engineering of cytochrome p450(cam) (CYP101) for the oxidation of polycyclic aromatic hydrocarbons. , 2000, Protein engineering.
[154] J. D. Bois,et al. Oxaziridine-Mediated Catalytic Hydroxylation of Unactivated 3° C−H Bonds Using Hydrogen Peroxide , 2005 .
[155] S. Bell,et al. Engineering the CYP101 system for in vivo oxidation of unnatural substrates. , 2001, Protein engineering.
[156] S. Bell,et al. The heme monooxygenase cytochrome P450cam can be engineered to oxidize ethane to ethanol. , 2005, Angewandte Chemie.
[157] L. Wong,et al. Oxidation of polychlorinated benzenes by genetically engineered CYP101 (cytochrome P450(cam)). , 2001, European journal of biochemistry.
[158] Heung-Chae Jung,et al. Generation of the Human Metabolite Piceatannol from the Anticancer-Preventive Agent Resveratrol by Bacterial Cytochrome P450 BM3 , 2009, Drug Metabolism and Disposition.
[159] Frances H Arnold,et al. Chemo-enzymatic fluorination of unactivated organic compounds. , 2009, Nature chemical biology.
[160] Dong-Sun Lee,et al. Substrate Recognition and Molecular Mechanism of Fatty Acid Hydroxylation by Cytochrome P450 from Bacillus subtilis , 2003, The Journal of Biological Chemistry.
[161] R. J. Kenny,et al. Evolved CYP102A1 (P450BM3) variants oxidise a range of non-natural substrates and offer new selectivity options. , 2008, Chemical communications.
[162] K. Suslick,et al. Shape selective alkane hydroxylation by metalloporphyrin catalysts , 1987 .
[163] G. B. Shul’pin,et al. ACTIVATION OF C-H BONDS BY METAL COMPLEXES , 1997 .
[164] M. Cryle,et al. Are branched chain fatty acids the natural substrates for P450(BM3)? , 2006, Chemical communications.
[165] F. Walker,et al. Chimeragenesis of the fatty acid binding site of cytochrome P450BM3. Replacement of residues 73-84 with the homologous residues from the insect cytochrome P450 CYP4C7. , 2004, Biochemistry.
[166] S. Bell,et al. Engineering the haem monooxygenase cytochrome P450cam for monoterpene oxidation , 2001 .
[167] Thomas C Pochapsky,et al. Conformational plasticity and structure/function relationships in cytochromes P450. , 2010, Antioxidants & redox signaling.
[168] M. Gelb,et al. Stereochemistry and deuterium isotope effects in camphor hydroxylation by the cytochrome P450cam monoxygenase system. , 1982, Biochemistry.
[169] N. Bruce,et al. LICRED: A Versatile Drop‐In Vector for Rapid Generation of Redox‐Self‐Sufficient Cytochrome P450s , 2010, Chembiochem : a European journal of chemical biology.
[170] J. Coggins,et al. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains. , 1996, European journal of biochemistry.
[171] Teruyuki Nagamune,et al. Intramolecular electron transfer in a cytochrome P450cam system with a site-specific branched structure. , 2006, Protein engineering, design & selection : PEDS.
[172] Ilme Schlichting,et al. Structure and chemistry of cytochrome P450. , 2005, Chemical reviews.
[173] Heung-Chae Jung,et al. Generation of Human Chiral Metabolites of Simvastatin and Lovastatin by Bacterial CYP102A1 Mutants , 2011, Drug Metabolism and Disposition.
[174] Frances H Arnold,et al. Cytochrome P450: taming a wild type enzyme. , 2011, Current opinion in biotechnology.
[175] S. Bell,et al. Structural Basis for the Properties of Two Single‐Site Proline Mutants of CYP102A1 (P450BM3) , 2010, Chembiochem : a European journal of chemical biology.
[176] S. Bell,et al. P450(BM3) (CYP102A1): connecting the dots. , 2012, Chemical Society reviews.
[177] Heung-Chae Jung,et al. Oxidation of human cytochrome P450 1A2 substrates by Bacillus megaterium cytochrome P450 BM3 , 2010 .
[178] M. Sutcliffe,et al. The catalytic mechanism of cytochrome P450 BM3 involves a 6 Å movement of the bound substrate on reduction , 1996, Nature Structural Biology.
[179] X. Ribas,et al. Stereospecific C-H oxidation with H2O2 catalyzed by a chemically robust site-isolated iron catalyst. , 2009, Angewandte Chemie.
[180] C. W. Fisher,et al. Purification and enzymatic properties of a recombinant fusion protein expressed in Escherichia coli containing the domains of bovine P450 17A and rat NADPH-P450 reductase. , 1994, Archives of biochemistry and biophysics.
[181] Hidehiko Hirakawa,et al. Molecular Assembly of P450 with Ferredoxin and Ferredoxin Reductase by Fusion to PCNA , 2010, Chembiochem : a European journal of chemical biology.
[182] K. R. Marshall,et al. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium. , 2004, Biochemistry.
[183] S. Sligar,et al. Molecular recognition in cytochrome P-450: mechanism for the control of uncoupling reactions. , 1993, Biochemistry.
[184] C. W. Fisher,et al. The function of recombinant cytochrome P450s in intact Escherichia coli cells: the 17 alpha-hydroxylation of progesterone and pregnenolone by P450c17. , 1997, Archives of biochemistry and biophysics.
[185] T. Poulos,et al. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[186] Braunegg,et al. The Concept of Docking/Protecting Groups in Biohydroxylation. , 1999, Angewandte Chemie.
[187] D. Monti,et al. Redox reactions catalyzed by isolated enzymes. , 2011, Chemical reviews.
[188] P. Ortiz de Montellano,et al. Rearrangement reactions catalyzed by cytochrome P450s. , 2011, Archives of biochemistry and biophysics.
[189] V. Urlacher,et al. Catalytic Hydroxylation in Biphasic Systems using CYP102A1 Mutants , 2005 .
[190] David Baker,et al. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3). , 2009, ACS chemical biology.
[191] T. Poulos,et al. Structural biology of redox partner interactions in P450cam monooxygenase: a fresh look at an old system. , 2011, Archives of biochemistry and biophysics.
[192] M. Waterman,et al. The use of random chimeragenesis to study structure/function properties of rat and human P450c17. , 2000, Archives of biochemistry and biophysics.
[193] T. Baillie,et al. Metabolism and toxicity of drugs. Two decades of progress in industrial drug metabolism. , 2008, Chemical research in toxicology.
[194] M. Sanford,et al. Transition metal catalyzed oxidative functionalization of carbon-hydrogen bonds , 2006 .
[195] T. Rushmore,et al. Bioreactor systems in drug metabolism: synthesis of cytochrome P450-generated metabolites. , 2000, Metabolic engineering.
[196] Y. Sakai,et al. PropaneMonooxygenase and NAD+-Dependent Secondary AlcoholDehydrogenase in Propane Metabolism by Gordonia sp.StrainTY-5 , 2003, Journal of bacteriology.
[197] A. Munro,et al. Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily. , 2007, Natural product reports.
[198] P. R. Montellano. Hydrocarbon hydroxylation by cytochrome P450 enzymes. , 2010 .
[199] P. Hlavica. Assembly of non-natural electron transfer conduits in the cytochrome P450 system: a critical assessment and update of artificial redox constructs amenable to exploitation in biotechnological areas. , 2009, Biotechnology advances.
[200] Frances H Arnold,et al. Engineered alkane-hydroxylating cytochrome P450(BM3) exhibiting nativelike catalytic properties. , 2007, Angewandte Chemie.
[201] Christopher A. Voigt,et al. Functional evolution and structural conservation in chimeric cytochromes p450: calibrating a structure-guided approach. , 2004, Chemistry & biology.
[202] Manfred T Reetz,et al. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution , 2011, Nature Chemistry.
[203] H. Weber,et al. The concept of docking and protecting groups in biohydroxylation. , 2001, Chemistry.
[204] G. Grogan. Cytochromes P450: exploiting diversity and enabling application as biocatalysts. , 2011, Current opinion in chemical biology.
[205] John A. Robinson,et al. An oxidative phenol coupling reaction catalyzed by oxyB, a cytochrome P450 from the vancomycin-producing microorganism. , 2004, Angewandte Chemie.
[206] F. Arnold,et al. A panel of cytochrome P450 BM3 variants to produce drug metabolites and diversify lead compounds. , 2009, Chemistry.
[207] N. Turner,et al. Identification of a New Class of Cytochrome P450 from a Rhodococcus sp , 2002, Journal of bacteriology.
[208] S. Bell,et al. Molecular recognition in (+)-alpha-pinene oxidation by cytochrome P450cam. , 2002, Journal of the American Chemical Society.
[209] T. Egawa,et al. Evidence for compound I formation in the reaction of cytochrome P450cam with m-chloroperbenzoic acid. , 1994, Biochemical and biophysical research communications.
[210] Eric F. Johnson,et al. Determinants of Cytochrome P450 2C8 Substrate Binding , 2008, Journal of Biological Chemistry.
[211] A. McDermott,et al. Observation of ligand binding to cytochrome P450 BM-3 by means of solid-state NMR spectroscopy. , 2005, Journal of the American Chemical Society.
[212] A. Parret,et al. A novel class of self-sufficient cytochrome P450 monooxygenases in prokaryotes. , 2002, Trends in microbiology.
[213] Huimin Zhao,et al. Inverting the enantioselectivity of P450pyr monooxygenase by directed evolution. , 2010, Chemical communications.
[214] N. Misawa,et al. Functional expression system for cytochrome P450 genes using the reductase domain of self-sufficient P450RhF from Rhodococcus sp. NCIMB 9784 , 2006, Applied Microbiology and Biotechnology.
[215] Mikhail G. Shapiro,et al. Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine , 2010, Nature Biotechnology.
[216] John H. White,et al. A Self-sufficient Cytochrome P450 with a Primary Structural Organization That Includes a Flavin Domain and a [2Fe-2S] Redox Center* , 2003, Journal of Biological Chemistry.
[217] R. Croteau,et al. Cytochrome P450 oxygenases of Taxol biosynthesis , 2006, Phytochemistry Reviews.
[218] J. Dawson,et al. Uncoupling Oxygen Transfer and Electron Transfer in the Oxygenation of Camphor Analogues by Cytochrome P450-CAM , 1995, The Journal of Biological Chemistry.
[219] G. Gilardi,et al. Engineering human cytochrome P450 enzymes into catalytically self-sufficient chimeras using molecular Lego , 2006, JBIC Journal of Biological Inorganic Chemistry.
[220] C. Helliwell,et al. Arabidopsis ent-kaurene oxidase catalyzes three steps of gibberellin biosynthesis. , 1999, Plant physiology.
[221] Ke Chen,et al. Total synthesis of eudesmane terpenes by site-selective C–H oxidations , 2009, Nature.
[222] M. Joyce,et al. A Single Mutation in Cytochrome P450 BM3 Induces the Conformational Rearrangement Seen upon Substrate Binding in the Wild-type Enzyme* , 2004, Journal of Biological Chemistry.
[223] E. G. Funhoff,et al. Cytochrome P450 Alkane Hydroxylases of the CYP153 Family Are Common in Alkane-Degrading Eubacteria Lacking Integral Membrane Alkane Hydroxylases , 2006, Applied and Environmental Microbiology.
[224] F. Arnold,et al. Directed Evolution of a Cytochrome P450 Monooxygenase for Alkane Oxidation , 2001 .
[225] David J. Schuller,et al. Crystal Structure of a Thermophilic Cytochrome P450 from the Archaeon Sulfolobus solfataricus * , 2000, The Journal of Biological Chemistry.
[226] J. Bercaw,et al. Understanding and exploiting C–H bond activation , 2002, Nature.